15857-70-2 Usage
General Description
(3,4-dihydro-2H-1-benzothiopyran-4-yl)ammonium chloride, also known as DBT, is a chemical compound classified as a benzothiopyran derivative. It exists in the form of an ammonium salt, with the chloride ion as the counterion. (3,4-dihydro-2H-1-benzothiopyran-4-yl)ammonium chloride is commonly used in organic and medicinal chemistry as a building block for the synthesis of various pharmaceuticals and other organic compounds. It is also known for its potential biological activities, including antifungal and antimicrobial properties. Additionally, research has shown that DBT may have potential applications in the treatment of neurological disorders. Overall, (3,4-dihydro-2H-1-benzothiopyran-4-yl)ammonium chloride is a versatile and important chemical compound with various potential applications in the field of chemistry and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 15857-70-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,8,5 and 7 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 15857-70:
(7*1)+(6*5)+(5*8)+(4*5)+(3*7)+(2*7)+(1*0)=132
132 % 10 = 2
So 15857-70-2 is a valid CAS Registry Number.
InChI:InChI:1S/C9H11NS.ClH/c10-8-5-6-11-9-4-2-1-3-7(8)9;/h1-4,8H,5-6,10H2;1H
15857-70-2Relevant articles and documents
IMINOPYRIDINE DERIVATIVE AND USE THEREOF
-
Page/Page column 46-47, (2011/01/12)
The present invention aims to provide a compound having a superior selective α1D adrenergic receptor antagonistic action and useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like.The present invention provides a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.The present invention aims to provide a compound having a superior selective ± 1D adrenergic receptor antagonistic action and useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like. The present invention provides a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.